$PMDI
PSYCHEMEDICS CORP

2015 Q4 Form 10-Q Financial Statement

#000114420415061395 Filed on October 29, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q3
Revenue $6.134M $7.084M $7.704M
YoY Change -9.29% -8.05% 9.2%
Cost Of Revenue $3.480M $3.628M $3.734M
YoY Change 6.1% -2.86% 29.71%
Gross Profit $2.652M $3.456M $3.970M
YoY Change -23.84% -12.95% -4.93%
Gross Profit Margin 43.23% 48.79% 51.53%
Selling, General & Admin $2.190M $2.513M $2.362M
YoY Change 1.39% 6.43% 5.73%
% of Gross Profit 82.58% 72.73% 59.49%
Research & Development $350.0K $392.0K $363.8K
YoY Change -2.78% 7.77% 78.97%
% of Gross Profit 13.2% 11.34% 9.16%
Depreciation & Amortization $630.0K $390.0K $280.0K
YoY Change 110.0% 39.29% 27.27%
% of Gross Profit 23.76% 11.28% 7.05%
Operating Expenses $2.540M $2.905M $2.725M
YoY Change 0.79% 6.61% 11.84%
Operating Profit $114.0K $550.0K $1.244M
YoY Change -88.1% -55.79% -28.46%
Interest Expense -$30.00K $31.41K $33.94K
YoY Change 0.0% -7.45%
% of Operating Profit -26.32% 5.71% 2.73%
Other Income/Expense, Net
YoY Change
Pretax Income $80.00K $520.8K $1.210M
YoY Change -91.4% -56.97% -30.43%
Income Tax -$100.0K -$275.6K $293.4K
% Of Pretax Income -125.0% -52.92% 24.24%
Net Earnings $185.0K $796.0K $917.0K
YoY Change -72.63% -13.2% -12.83%
Net Earnings / Revenue 3.02% 11.24% 11.9%
Basic Earnings Per Share $0.03 $0.15 $0.17
Diluted Earnings Per Share $0.03 $0.15 $0.17
COMMON SHARES
Basic Shares Outstanding 5.423M shares 5.423M shares 5.375M shares
Diluted Shares Outstanding 5.425M shares 5.389M shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.690M $1.720M $2.610M
YoY Change -25.48% -34.1% -8.1%
Cash & Equivalents $2.689M $1.720M $2.612M
Short-Term Investments
Other Short-Term Assets $1.060M $1.890M $1.510M
YoY Change -0.93% 25.17% 5.59%
Inventory
Prepaid Expenses
Receivables $3.539M $5.450M $5.760M
Other Receivables $840.0K $440.0K $0.00
Total Short-Term Assets $8.129M $9.500M $9.880M
YoY Change -23.14% -3.85% 3.38%
LONG-TERM ASSETS
Property, Plant & Equipment $13.13M $13.07M $12.83M
YoY Change 3.08% 1.87% 158.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $774.0K $760.0K $730.0K
YoY Change 1.7% 4.11% 32.02%
Total Long-Term Assets $13.91M $13.83M $13.55M
YoY Change 3.01% 2.07% 146.03%
TOTAL ASSETS
Total Short-Term Assets $8.129M $9.500M $9.880M
Total Long-Term Assets $13.91M $13.83M $13.55M
Total Assets $22.04M $23.33M $23.43M
YoY Change -8.48% -0.43% 55.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $747.0K $640.0K $680.0K
YoY Change -11.61% -5.88% 17.83%
Accrued Expenses $1.198M $1.400M $1.970M
YoY Change -11.35% -28.93% 23.24%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.620M $1.620M $1.400M
YoY Change 15.72% 15.72%
Total Short-Term Liabilities $3.565M $3.650M $4.055M
YoY Change -0.87% -9.99% 86.39%
LONG-TERM LIABILITIES
Long-Term Debt $4.272M $4.680M $5.198M
YoY Change -11.88% -9.97%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $4.272M $4.680M $5.198M
YoY Change -11.88% -9.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.565M $3.650M $4.055M
Total Long-Term Liabilities $4.272M $4.680M $5.198M
Total Liabilities $10.36M $11.13M $10.57M
YoY Change -7.82% 5.32% 253.41%
SHAREHOLDERS EQUITY
Retained Earnings -$8.296M -$6.436M
YoY Change 26.35% -2.94%
Common Stock $30.05M $29.38M
YoY Change 1.93% 2.05%
Preferred Stock
YoY Change
Treasury Stock (at cost) $10.08M $10.08M
YoY Change 0.0% 0.0%
Treasury Stock Shares 668.0K shares 668.1K shares 668.1K shares
Shareholders Equity $11.67M $12.20M $12.86M
YoY Change
Total Liabilities & Shareholders Equity $22.04M $23.33M $23.43M
YoY Change -8.48% -0.42% 55.52%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income $185.0K $796.0K $917.0K
YoY Change -72.63% -13.2% -12.83%
Depreciation, Depletion And Amortization $630.0K $390.0K $280.0K
YoY Change 110.0% 39.29% 27.27%
Cash From Operating Activities $2.620M $100.0K $1.760M
YoY Change 4.8% -94.32% 3.53%
INVESTING ACTIVITIES
Capital Expenditures -$350.0K -$480.0K -$1.290M
YoY Change 45.83% -62.79% 89.71%
Acquisitions
YoY Change
Other Investing Activities -$30.00K -$20.00K -$50.00K
YoY Change -25.0% -60.0% -61.54%
Cash From Investing Activities -$370.0K -$510.0K -$1.340M
YoY Change 27.59% -61.94% 67.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.270M 20.00K -160.0K
YoY Change 4.96% -112.5% -79.49%
NET CHANGE
Cash From Operating Activities 2.620M 100.0K 1.760M
Cash From Investing Activities -370.0K -510.0K -1.340M
Cash From Financing Activities -1.270M 20.00K -160.0K
Net Change In Cash 980.0K -390.0K 260.0K
YoY Change -2.0% -250.0% 116.67%
FREE CASH FLOW
Cash From Operating Activities $2.620M $100.0K $1.760M
Capital Expenditures -$350.0K -$480.0K -$1.290M
Free Cash Flow $2.970M $580.0K $3.050M
YoY Change 8.39% -80.98% 28.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
5037 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
20841415 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
22443005 USD
us-gaap Cost Of Services
CostOfServices
10776122 USD
us-gaap Cost Of Services
CostOfServices
10786382 USD
us-gaap Gross Profit
GrossProfit
10065293 USD
us-gaap Gross Profit
GrossProfit
11656623 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1284914 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
986201 USD
us-gaap Operating Expenses
OperatingExpenses
8707548 USD
us-gaap Operating Expenses
OperatingExpenses
7924652 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1357745 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
3731971 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-94614 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-29157 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1263131 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3702814 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-63106 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1172836 USD
us-gaap Net Income Loss
NetIncomeLoss
1326237 USD
us-gaap Net Income Loss
NetIncomeLoss
2529978 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5399131 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5348730 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5406053 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5375472 shares
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
751306 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1102112 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
176648 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
225138 USD
us-gaap Share Based Compensation
ShareBasedCompensation
448417 USD
us-gaap Share Based Compensation
ShareBasedCompensation
514422 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1388452 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1375031 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-286221 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-787769 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
172696 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-209627 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-667621 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
43335 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1955897 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1964079 USD
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
321394 USD
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
310981 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6993673 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1091683 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-7517350 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1425675 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2406007 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2428639 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
4202653 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-2428663 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1358800 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1890259 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3970512 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2611712 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
461920 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
2870 USD
us-gaap Interest Paid
InterestPaid
42285 USD
us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
202283 USD
us-gaap Interest Paid
InterestPaid
94385 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
191566 USD
us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
23011 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
47564 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
91556 USD
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
1098539 USD
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
6999626 USD
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
1049944 USD
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
401562 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
140175 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
36968 USD
CY2014Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
14000 shares
CY2015Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
7000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
26000 shares
CY2015Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1620000 USD
CY2015Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1620000 USD
CY2015Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1620000 USD
CY2015Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
868000 USD
CY2015Q3 us-gaap Long Term Debt
LongTermDebt
6297000 USD
CY2015Q3 us-gaap Interest Expense
InterestExpense
31411 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
PSYCHEMEDICS CORP
dei Entity Central Index Key
EntityCentralIndexKey
0000806517
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
PMD
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5422541 shares
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
61992 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
95525 USD
CY2015Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6537560 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5788551 USD
CY2015Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
668130 shares
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
668130 shares
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.005
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.005
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
872521 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
872521 shares
CY2015Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6090671 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6043191 shares
CY2015Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
405000 USD
CY2015Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
164000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1800000 USD
CY2014Q3 us-gaap Interest Expense
InterestExpense
33941 USD
CY2014Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0215 pure
us-gaap Interest Expense
InterestExpense
46958 USD
CY2015Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0218 pure
us-gaap Interest Expense
InterestExpense
95216 USD
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
89000 shares
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
182000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
73000 shares

Files In Submission

Name View Source Status
0001144204-15-061395-index-headers.html Edgar Link pending
0001144204-15-061395-index.html Edgar Link pending
0001144204-15-061395.txt Edgar Link pending
0001144204-15-061395-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pmd-20150930.xml Edgar Link completed
pmd-20150930.xsd Edgar Link pending
pmd-20150930_cal.xml Edgar Link unprocessable
pmd-20150930_def.xml Edgar Link unprocessable
pmd-20150930_lab.xml Edgar Link unprocessable
pmd-20150930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tlogo_ex10-4.jpg Edgar Link pending
v422481_10q.htm Edgar Link pending
v422481_ex10-1.htm Edgar Link pending
v422481_ex10-2.htm Edgar Link pending
v422481_ex10-3.htm Edgar Link pending
v422481_ex10-4.htm Edgar Link pending
v422481_ex31-1.htm Edgar Link pending
v422481_ex31-2.htm Edgar Link pending
v422481_ex32-1.htm Edgar Link pending
v422481_ex32-2.htm Edgar Link pending